ABRYSVO for the prevention of LRTD by syncytial virus
Tradename: ABRYSVO Proper Name: Respiratory Syncytial Virus Vaccine Indication: Indicated for active immunization of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory…